CUAMC
IONS icon

China Universal Asset Management Company’s Ionis Pharmaceuticals IONS Stock Holding History

China Universal Asset Management Company’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05M Sell
76,302
-1,013
-1% -$76.2K 0.36% 56
2026
Q1 		$5.81M Buy
77,315
+34,921
+82% +$2.76M 0.44% 52
2025
Q4 		$3.35M Buy
42,394
+14,455
+52% +$1.09M 0.26% 71
2025
Q3 		$1.83M Sell
27,939
-4,027
-13% -$197K 0.15% 120
2025
Q2 		$1.26M Buy
31,966
+80
+0.3% +$2.62K 0.12% 148
2025
Q1 		$962K Sell
31,886
-1,594
-5% -$52.2K 0.09% 190
2024
Q4 		$1.17M Buy
33,480
+5,359
+19% +$200K 0.11% 142
2024
Q3 		$1.13M Buy
28,121
+10,971
+64% +$510K 0.12% 131
2024
Q2 		$817K Sell
17,150
-10,877
-39% -$446K 0.12% 115
2024
Q1 		$1.21M Buy
28,027
+11,429
+69% +$545K 0.15% 112
2023
Q4 		$840K Buy
16,598
+12,928
+352% +$619K 0.16% 119
2023
Q3 		$166K Buy
3,670
+1,795
+96% +$74.1K 0.05% 158
2023
Q2 		$76.9K Sell
1,875
-62
-3% -$2.38K 0.02% 165
2023
Q1 		$69.2K Buy
1,937
+494
+34% +$18.6K 0.02% 142
2022
Q4 		$54.5K Buy
1,443
+114
+9% +$4.79K 0.02% 135
2022
Q3 		$59K Buy
+1,329
New +$56K 0.02% 120

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

China Universal Asset Management Company's IONS Position: Q2 2026 in Review

China Universal Asset Management Company reduced its Ionis Pharmaceuticals (IONS) stake by 1.3% in Q2 2026, selling an estimated $76.2K and leaving 76,302 shares worth $6.05M. The position accounts for 0.36% of the portfolio, ranked #56.

China Universal Asset Management Company first reported a position in IONS in Q3 2022 and has held it in 16 quarters since. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • China Universal Asset Management Company held 76,302 shares of Ionis Pharmaceuticals worth $6.05M as of Q2 2026.
  • China Universal Asset Management Company sold 1,013 Ionis Pharmaceuticals shares in Q2 2026, an estimated $76.2K.
  • Ionis Pharmaceuticals made up 0.36% of China Universal Asset Management Company's portfolio in Q2 2026, its #56 holding.
  • China Universal Asset Management Company first reported a position in Ionis Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • 515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.